Bain Capital Life Sciences Opportunities III, LP - Insider Non-Derivative Transactions at Kyverna Therapeutics, Inc. (KYTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 12, 2024, Bain Capital Life Sciences Opportunities III, LP's relationship to Kyverna Therapeutics, Inc. (KYTX) is TenPercentOwner, and currently has 3,163,868 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KYTX insiders.
Data Source: SEC.
Bain Capital Life Sciences Opportunities III, LP - Insider Non-Derivative Transactions at KYTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 13, 2024 | C -- (Common Stock) | 2713868 | 0 | 2713868 |
| Feb 13, 2024 | P -- (Common Stock) | 450000 | 22 | 3163868 |